The global COVID-19 pandemic has shaken the globe to its core over the past two years. The cause of both a public health and an economic crisis, the pandemic has been described as the biggest threat to civilization since the end of the Second World War II. One of the main defenses against COVID-19 is the effective roll-out of the vaccines which were researched, developed, tested, regulated and rolled out in just two years. By any stretch of the imagination, this is a remarkable achievement, especially when you consider that many people around the world have now received their third dose. One of the main ongoing logistical issues with the vaccine centers around distribution and storage, due to a need for some of the vaccines to be stored at extremely low temperatures. This led to Thermo Fisher Scientific looking for a bespoke packaging solution, one that enabled work to be carried out within the low temperatures and specific timescales needed.
By Alf Goebel, CEO of advanco.